BRIEF published on 05/13/2026 at 07:48, 3 days 4 hours ago Rapport de performance financière de Dermapharm Holding SE pour le premier trimestre 2026 Résultats Financiers Acquisitions Croissance Des Revenus Médicaments De Marque Confirmation Des Directives
BRIEF published on 05/13/2026 at 07:48, 3 days 4 hours ago Dermapharm Holding SE Q1 2026 Financial Performance Report Financial Results Revenue Growth Acquisitions Guidance Confirmation Branded Pharmaceuticals
PRESS RELEASE published on 05/13/2026 at 07:43, 3 days 4 hours ago Dermapharm Holding SE performs in line with projections in Q1 2026 and confirms guidance Dermapharm Holding SE reports Q1 2026 results: 1.1% revenue growth to EUR 305.8 million, EBITDA up 7.5% to EUR 87.4 million. Confirms guidance for 2026 EBITDA Revenue Growth Dermapharm Holding SE Q1 2026 2026 Guidance
BRIEF published on 03/31/2026 at 07:35, 1 month 16 days ago Dermapharm Holding SE prévoit des résultats financiers mitigés en 2025 Baisse Des Revenus Augmentation De L'EBITDA Croissance Des Produits Pharmaceutiques De Marque Stabilité Des Produits De Santé Dépôt D'importation Parallèle
BRIEF published on 03/31/2026 at 07:35, 1 month 16 days ago Dermapharm Holding SE sees mixed financial outcomes in 2025 Revenue Decline EBITDA Increase Branded Pharmaceuticals Growth Healthcare Products Stability Parallel Import Drop
PRESS RELEASE published on 03/31/2026 at 07:30, 1 month 16 days ago Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin Dermapharm Holding SE reports dip in revenue but rise in adjusted consolidated EBITDA and margin for the 2025 financial year, with expectations of further growth in 2026 Adjusted EBITDA Dermapharm Holding SE Revenue Dip Financial Year 2025 Margin Rise
BRIEF published on 03/26/2026 at 20:53, 1 month 20 days ago Dermapharm Executes Share Buyback Amid Strong Interest Share Buyback Financial Management Treasury Shares Stock Market Dermapharm
BRIEF published on 03/26/2026 at 20:53, 1 month 20 days ago Dermapharm procède à un rachat d'actions face à un fort intérêt Rachat D'actions Marché Boursier Gestion Financière Dermapharm Actions Du Trésor
PRESS RELEASE published on 03/26/2026 at 20:48, 1 month 20 days ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer. Company's buyback program exceeded maximum shares tendered. Offer price to be available by 2 April 2026 Share Buyback Treasury Shares Public Offer Dermapharm Holding SE Stock Repurchase
BRIEF published on 03/10/2026 at 09:16, 2 months 6 days ago Dermapharm Holding SE Announces Share Buyback Offer Share Buyback Dermapharm Holding SE Capital Measures 4,300,000 Shares EUR 42.00 Per Share
Published on 05/16/2026 at 01:15, 10 hours 52 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 12 hours 7 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 12 hours 57 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 13 hours 7 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 15 hours 57 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 17 hours 56 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 18 hours 33 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 20 hours 59 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 21 hours 7 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 1 hour ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 3 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 18 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
